Healthy Clinical Trial
Official title:
The Effect of Combining Maximal Mental Effort With Elastic Band Training on Strength and Neuromuscular Adaptations in Older Females
The goal of this clinical trial is to determine the effect of maximal mental effort combined with elastic band training on strength and neuromuscular function in healthy, older females. The main questions it aims to answer are: - Does elastic band training in combination with maximal mental effort increase strength more than elastic band training alone? - Does elastic band training in combination with maximal mental effort improve neuromuscular function more than elastic band training alone? Participants will be randomly assigned to 1 of 3 groups: - Elastic band training - Elastic band training with maximal mental effort - Control Researchers will compare groups to determine differences in changes in strength, neuromuscular function, and body composition.
Status | Recruiting |
Enrollment | 45 |
Est. completion date | November 1, 2024 |
Est. primary completion date | November 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 65 Years to 79 Years |
Eligibility | Inclusion Criteria: - Between 65-79 years of age - Female - Have not engaged in structured exercise for 3 years - Are not reliant upon a walking aid - Be able to rise from a chair unassisted - BMI between 25-33 kg/m² - Have access to the internet and access to a smartphone or computer with a camera at home Exclusion Criteria: - Any history of cardiovascular, cerebrovascular, or metabolic diseases - Musculoskeletal injury within the past 6 months - Any condition affecting muscle function - Uncontrolled hypertension - Score less than 23 on the Mini-mental State Exam - Upon starting study, missing more than 2 training session |
Country | Name | City | State |
---|---|---|---|
United States | Kennesaw State University | Kennesaw | Georgia |
United States | Kennesaw State University | Kennesaw | Georgia |
Lead Sponsor | Collaborator |
---|---|
Kennesaw State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in exercising heart rate | A descriptor of the exercise physiological intensity for both training protocols | Each exercise session of the 6-week intervention | |
Other | Change in calorie consumption as measured by kilocalories determined by dietary recall | Amount of calories consumed | Baseline, Week 7 | |
Other | Change in protein consumption as measured by kilocalories determined by dietary recall | Amount of protein consumed | Baseline, Week 7 | |
Other | Change in physical activity as measured by daily step count via Garmin Venu SQ smartwatch | Measure of physical activity level | Baseline, Week 7 | |
Primary | Change in bicep curl strength as measured by load lifted in pounds | Maximum dumbbell load lifted successfully throughout the range of motion of a bicep curl | Baseline, Week 7 | |
Secondary | Change in voluntary activation as measured by ratio of superimposed torque to resting twitch torque | Voluntary activation is an estimate of neural drive and is the amplitude of superimposed torque elicited by percutaneous muscle stimulation relative to the resting twitch torque amplitude | Baseline, Week 7 | |
Secondary | Change in handgrip strength as measured in kilograms of force | Upper-body strength as measured by a handgrip dynamometer | Baseline, Week 7 | |
Secondary | Change in agonist muscle activation as measured by electromyography amplitude | A measure of the capacity at which the muscle is activitated by the nervous system | Baseline, Week 7 | |
Secondary | Change from baseline in isokinetic muscle activation at 6 weeks | Electromyography root mean square during isokinetic contraction divided by root mean square during isometric contraction | Baseline, Week 7 | |
Secondary | Change in antagonist co-activation as measured by electromyography amplitude | A measure of the capacity at which the antagonist muscle is activated by the nervous system | Baseline, Week 7 | |
Secondary | Change in isometric bicep strength as measured by newton-meters of torque | Isometric strength of a muscle | Baseline, Week 7 | |
Secondary | Change in isokinetic bicep strength as measured by newton-meters of torque | Dynamic strength of a muscle contracting at a constant velocity | Baseline, Week 7 | |
Secondary | Change in rate of torque development as measured by newton-meters per second | A measure of the capacity to increase muscle torque rapidly as determined by the slope of the torque-time curve | Baseline, Week 7 | |
Secondary | Change in walking speed as measured by time taken to walk 6 meters | Measure of lower-body physical function | Baseline, Week 7 | |
Secondary | Change in chair rise performance as measured by number of chair rises performed in 30 seconds | Measure of lower-body physical function | Baseline, Week 7 | |
Secondary | Change in chair rise power by watts by a linear transducer attached to hip during chair rise test | Product of load and velocity as determined on a linear transducer | Baseline, Week 7 | |
Secondary | Change in muscle composition as measured by ultrasound-derived grey-scale analysis | Echo-intensity value derived from grey-scale analysis is indicative of amount of non-contractile tissue in muscle | Baseline, Week 7 | |
Secondary | Change in skeletal muscle size as measured by ultrasound-derived cross-sectional | Size of a muscle | Baseline, Week 7 | |
Secondary | Change in fat mass as measured by kilograms | Amount of fat tissue a person possesses estimated by bioelectrical impedance analysis | Baseline, Week 7 | |
Secondary | Change in fat-free mass as measured by kilograms | Amount of non-fat tissue a person possesses estimated by bioelectrical impedance analysis | Baseline, Week 7 | |
Secondary | Change in body fat percentage as measured by fat tissue relative to fat-free tissue | Relative amount of body fat a person possesses estimated by bioelectrical impedance analysis | Baseline, Week 7 | |
Secondary | Change in hemoglobin A1c level as measured by blood drop analysis | Blood drop analysis, obtained from fingerstick, measure of amount of blood sugar bound to hemoglobin | Baseline, Week 7 | |
Secondary | Change in resting heart rate as measured by beats/min using oscillatory cuff | Measure of cardiovascular fitness | Baseline, Week 7 | |
Secondary | Change in resting blood pressure in millimeters of mercury using oscillatory cuff | Measure of cardiovascular fitness | Baseline, Week 7 | |
Secondary | Change in general feeling about knee extension and bicep curl exercise | From a -5 to +5 on the Affective Feeling Scale | Each exercise session of the 6-week intervention | |
Secondary | Change in grip width on elastic band as measured by distance of hand placements on band | Indication of progression in training intensity | Baseline, 3 weeks, 5 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |